Treatment of Renal Artery Fibromuscular Dysplasia

Michael A. Meuse, Ulku C. Turba, Saher S. Sabri, Auh Whan Park, Wael E.A. Saad, J. Fritz Angle, Alan H. Matsumoto

Research output: Contribution to journalReview articlepeer-review

21 Scopus citations


Fibromuscular dysplasia is a nonatherosclerotic and noninflammatory disease that can result in stenoses of the renal arteries and hypertension, most commonly affecting middle-aged women. Percutaneous transluminal angioplasty has long been considered the mainstay of therapy and offers high rates of improved or cured hypertension. The disease involves the mid and distal renal arteries and branchpoints and poses endovascular treatment challenges that separate fibromuscular dysplasia from atherosclerotic disease. The development of smaller balloon dilation systems offers safe and highly effective endovascular treatment options for technically difficult lesions. Newer technologies such as cutting balloons also add to the armamentarium of treatment choices, which may be useful in the setting of resistant stenoses. This article focuses on the modern technical considerations in the diagnostic evaluation and endovascular treatment of renal artery fibromuscular dysplasia.

Original languageEnglish (US)
Pages (from-to)126-133
Number of pages8
JournalTechniques in Vascular and Interventional Radiology
Issue number2
StatePublished - Jun 2010
Externally publishedYes


  • balloon angioplasty
  • fibromuscular dysplasia
  • renal arteries

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Treatment of Renal Artery Fibromuscular Dysplasia'. Together they form a unique fingerprint.

Cite this